FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023201066> ?p ?o ?g. }

• W2023201066 endingPage "27" @default.
• W2023201066 startingPage "22" @default.
• W2023201066 abstract "Background: Endocrinopathies are common in patients with thalassaemia major (TM) despite parenteral iron chelation therapy with deferoxamine. There are only a few studies on the efficacy of oral deferiprone in preventing endocrine dysfunction.Aim: To determine the growth and endocrine complications in children with TM receiving oral iron chelation with deferiprone.Methods: All adolescents with TM receiving regular blood transfusion and deferiprone were evaluated prospectively for growth and pubertal status over a 1-year period. Tests for endocrine function included oral glucose tolerance test, calcium, phosphate, alkaline phosphatase, parathyroid hormone and thyroid profile and, in those with delayed/arrested puberty, sex steroids and gonadotropins. Clonidine-stimulated growth hormone (GH) was measured in patients with height ≤−3 SD.Results: 89 patients [51 males, 38 females, mean (SD) age 13·6 (2·5) years] were evaluated. Mean (SD) pre-transfusion haemoglobin was 9·2 (1·1) g/dl and the mean (SD) age of starting deferiprone was 5·1 (2·4) years. Mean (SD) ferritin was 9159 (3312) pmol/L (normal <2247). 49 (55%) subjects were of short stature and 25 (27%) had a height Z-score ≤ −3. GH testing was performed in 19 patients, of whom 17 had peak GH values <10 μg/L. Delayed puberty and/or hypogonadism was present in 54·1% patients at or beyond the age of normal puberty. Impaired glucose tolerance/diabetes mellitus, hypoparathyroidism and primary hypothyroidism (subclinical) were present in 13·0%, 10·1% and 8·9%, respectively. Overall, 44 (49·4%) adolescents had at least one endocrinopathy.Conclusion: Adolescents with TM on oral iron chelation therapy with deferiprone experienced a high prevalence of growth faltering and endocrinopathies which was comparable to that previously reported with deferoxamine. A combination of deferoxamine and deferiprone may be necessary to prevent growth and endocrine problems." @default.
• W2023201066 created "2016-06-24" @default.
• W2023201066 creator A5001555201 @default.
• W2023201066 creator A5008904731 @default.
• W2023201066 creator A5017406120 @default.
• W2023201066 creator A5043109886 @default.
• W2023201066 creator A5044847108 @default.
• W2023201066 creator A5052724921 @default.
• W2023201066 creator A5059129090 @default.
• W2023201066 date "2014-10-13" @default.
• W2023201066 modified "2023-09-27" @default.
• W2023201066 title "Endocrinopathies in adolescents with thalassaemia major receiving oral iron chelation therapy" @default.
• W2023201066 cites W1690203769 @default.
• W2023201066 cites W1789952979 @default.
• W2023201066 cites W1907915660 @default.
• W2023201066 cites W1976870764 @default.
• W2023201066 cites W1979220493 @default.
• W2023201066 cites W2009982467 @default.
• W2023201066 cites W2017444100 @default.
• W2023201066 cites W2021953494 @default.
• W2023201066 cites W2039282345 @default.
• W2023201066 cites W2060664419 @default.
• W2023201066 cites W2061809972 @default.
• W2023201066 cites W2064129324 @default.
• W2023201066 cites W2073526322 @default.
• W2023201066 cites W2078982459 @default.
• W2023201066 cites W2079399520 @default.
• W2023201066 cites W2107026509 @default.
• W2023201066 cites W2161209070 @default.
• W2023201066 cites W2726382541 @default.
• W2023201066 cites W4249395130 @default.
• W2023201066 cites W4253887979 @default.
• W2023201066 doi "https://doi.org/10.1179/2046905514y.0000000160" @default.
• W2023201066 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25311879" @default.
• W2023201066 hasPublicationYear "2014" @default.
• W2023201066 type Work @default.
• W2023201066 sameAs 2023201066 @default.
• W2023201066 citedByCount "25" @default.
• W2023201066 countsByYear W20232010662016 @default.
• W2023201066 countsByYear W20232010662017 @default.
• W2023201066 countsByYear W20232010662018 @default.
• W2023201066 countsByYear W20232010662019 @default.
• W2023201066 countsByYear W20232010662020 @default.
• W2023201066 countsByYear W20232010662021 @default.
• W2023201066 countsByYear W20232010662022 @default.
• W2023201066 countsByYear W20232010662023 @default.
• W2023201066 crossrefType "journal-article" @default.
• W2023201066 hasAuthorship W2023201066A5001555201 @default.
• W2023201066 hasAuthorship W2023201066A5008904731 @default.
• W2023201066 hasAuthorship W2023201066A5017406120 @default.
• W2023201066 hasAuthorship W2023201066A5043109886 @default.
• W2023201066 hasAuthorship W2023201066A5044847108 @default.
• W2023201066 hasAuthorship W2023201066A5052724921 @default.
• W2023201066 hasAuthorship W2023201066A5059129090 @default.
• W2023201066 hasConcept C126322002 @default.
• W2023201066 hasConcept C134018914 @default.
• W2023201066 hasConcept C187212893 @default.
• W2023201066 hasConcept C2775941721 @default.
• W2023201066 hasConcept C2776354409 @default.
• W2023201066 hasConcept C2776517179 @default.
• W2023201066 hasConcept C2776672577 @default.
• W2023201066 hasConcept C2777218474 @default.
• W2023201066 hasConcept C2777799968 @default.
• W2023201066 hasConcept C2777871287 @default.
• W2023201066 hasConcept C2779952775 @default.
• W2023201066 hasConcept C2984496839 @default.
• W2023201066 hasConcept C46699223 @default.
• W2023201066 hasConcept C71315377 @default.
• W2023201066 hasConcept C71924100 @default.
• W2023201066 hasConcept C89551170 @default.
• W2023201066 hasConcept C90924648 @default.
• W2023201066 hasConceptScore W2023201066C126322002 @default.
• W2023201066 hasConceptScore W2023201066C134018914 @default.
• W2023201066 hasConceptScore W2023201066C187212893 @default.
• W2023201066 hasConceptScore W2023201066C2775941721 @default.
• W2023201066 hasConceptScore W2023201066C2776354409 @default.
• W2023201066 hasConceptScore W2023201066C2776517179 @default.
• W2023201066 hasConceptScore W2023201066C2776672577 @default.
• W2023201066 hasConceptScore W2023201066C2777218474 @default.
• W2023201066 hasConceptScore W2023201066C2777799968 @default.
• W2023201066 hasConceptScore W2023201066C2777871287 @default.
• W2023201066 hasConceptScore W2023201066C2779952775 @default.
• W2023201066 hasConceptScore W2023201066C2984496839 @default.
• W2023201066 hasConceptScore W2023201066C46699223 @default.
• W2023201066 hasConceptScore W2023201066C71315377 @default.
• W2023201066 hasConceptScore W2023201066C71924100 @default.
• W2023201066 hasConceptScore W2023201066C89551170 @default.
• W2023201066 hasConceptScore W2023201066C90924648 @default.
• W2023201066 hasIssue "1" @default.
• W2023201066 hasLocation W20232010661 @default.
• W2023201066 hasLocation W20232010662 @default.
• W2023201066 hasOpenAccess W2023201066 @default.
• W2023201066 hasPrimaryLocation W20232010661 @default.
• W2023201066 hasRelatedWork W2023201066 @default.
• W2023201066 hasRelatedWork W2109853368 @default.
• W2023201066 hasRelatedWork W2134461465 @default.
• W2023201066 hasRelatedWork W2139685175 @default.
• W2023201066 hasRelatedWork W2187575468 @default.

• next